Nirvana Life Sciences IncCanadian Securities Exchange:NIRVView on Grey Market
- LAST PRICE0.0750
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0100/ 1
- Ask / Lots0.3300/ 1
- Open / Previous Close--- / 0.0750
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nirvana Life Sciences Inc | 2.5M | -2.3x | --- |
Algernon Pharmaceuticals Inc | 2.2M | -0.4x | --- |
CVR Medical Corp | 2.0M | -0.6x | --- |
Psyence Group Inc | 2.1M | 0.0x | --- |
Revive Therapeutics Ltd | 2.1M | -0.7x | --- |
PsyBio Therapeutics Corp | 1.3M | -0.3x | --- |
Company Information
Nirvana Life Sciences Inc. is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The Company has selected two products for its first phase of development: a one-per-day slow release gel cap that assists transition from opioids to non-addictive pain relief therapies, and a one-per-day slow release gel cap that delivers non-addictive pain relief. Any number of therapeutic medicines and products are created from its formulations. The Company is also engaged in growing several genera and species of fungi (including rare and hybrid varieties) with a batch consistency.
Contact Information
- Headquarters
- 6th Floor. 905 West Pender StVANCOUVER, BC, Canada V6C1L6
- Phone
- 604-689-1280
- Fax
- 604-401-8100
Executives
- Chairman of the Board
- Rich West
- Chief Executive Officer
- Russell Thomas
- Chief Scientific Officer
- Bruce Pitner
- Vice President - Operations
- Christopher Macnevin
- Chief Alliance Officer
- Preston Linn
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 33.0M |
Nirvana Life Sciences Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.03 |
Book Value | $-0.03 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
